Desk›Healthcare› Aptus Pharma Ltd
Aptus Pharma Ltd
BSE 544529 · NSE APPL · ISIN INE15XJ01010 · Group MT · Active
Healthcare › Healthcare › Pharmaceuticals & Biotechnology › Pharmaceuticals
₹320.70
+1.99%
BSE close, 28 August 2026
₹550.00 cr
1.7 cr shares · Micro cap
₹149.13 cr
as published
119.2× · —
EPS ₹2.69 · BV —
46.58 / 4.62
₹ cr, as filed
15
3 selected · 20%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | +0.0% |
|---|---|
| Against 52-week low | +892.3% |
| Day change | +1.99% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹2.69 |
|---|---|
| Price / earnings | 119.22× |
| Price / book | — |
| Book value — derived, price ÷ P/B | — |
| Return on equity | — |
| Operating margin | — |
| Net margin | — |
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Mar-26 · Q | 32.20 | 2.87 | 4.19 | 14.34% | 8.92% |
| Sep-25 · Q | 14.38 | 1.75 | 3.46 | 20.62% | 12.15% |
| FY25-26 | 46.58 | 4.62 | 7.78 | 16.28% | 9.92% |
Quarter on quarter
- Revenue, quarter on quarter
- +123.9%
- Net profit, quarter on quarter
- +64.0%
- Operating margin, quarter on quarter
- -628 bps
Disclosure profile 15 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Investor Presentation | 1 |
| Press Release | 1 |
| Selected sub-total | 3 |
| Procedural | |
| AGM / EGM | 4 |
| Board Meeting | 2 |
| Analyst / Investor Meet | 1 |
| Annual Report | 1 |
| Compliance Certificate | 1 |
| General | 1 |
| Newspaper Publication | 1 |
| Trading Window | 1 |
| Procedural sub-total | 12 |
| Total | 15 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group MT, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
15 filings · 3 selected · busiest 2026-08-21
Filing rhythm · the twelve most recent
2026-08-172026-10-09
SelectedProcedural
Filings
15 in the window · 3 earlier on record
-
9 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Compliance Certificate uner Reg. 74 (5) of SEBI (DP) Regulations, 2018
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
28 September 2026 ·
Closure of Trading Window
Closure of trading window under Insider Trading Code
Insider Trading / SAST / Closure of Trading Window View filing →
-
17 September 2026 ·
Analyst / Investor Meet - Intimation
Intimation of Investor Meeting/Interaction
Company Update / Analyst / Investor Meet View filing →
-
14 September 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Scrutinizer's Report on remote E-Voting
AGM/EGM / AGM View filing →
-
14 September 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Summary of proceedings of the 16th Annual General Meeting of the Company held on 14th September, 2026
AGM/EGM / AGM View filing →
-
9 September 2026 ·
Newspaper Publication
Submission of Newspaper Advertisement
Company Update / Newspaper Publication View filing →
-
7 September 2026 ·
CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING
CORRIGENDUM / ADDENDUM TO NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING
AGM/EGM / AGM View filing →
-
24 August 2026 ·
Press Release / Media Release
Aptus Pharma Limited - Press release regarding - Aptus Pharma Limited charts next growth phase with focus on manufacturing, pan-India expansion and global markets
Company Update / Press Release / Media Release View filing →
-
21 August 2026 ·
Investor Presentation
Intimation of investor presentation under regulation 30 of SEBI (LODR) Regulations, 2015
Company Update / Investor Presentation View filing →
-
21 August 2026 ·
Reg. 34 (1) Annual Report.
SUB: Submission of Annual Report for the FY 2025-26 comprising of the Notice of Annual General Meeting, Directors Report, Independent Auditors Report and Audited Financial Statements
Others / Reg. 34 (1) Annual Report View filing →
-
21 August 2026 ·
NOTICE OF ANNUAL GENERAL MEETING AND E-VOTING
Notice is hereby given that the Annual General Meeting of the Company will be held on Monday 14th September, 2026, Through Video Conferencing (VC)/ Other Audio visual means.
AGM/EGM / AGM View filing →
-
17 August 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting Dated 17.08.2026
Outcome of Board Meeting dated 17.08.2026
Board Meeting / Outcome of Board Meeting View filing →
-
12 August 2026 ·
Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Monday, August 17, 2026
Aptus Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/08/2026 ,inter alia, to consider and approve Prior Intimation of Board Meeting ....
Board Meeting / Board Meeting View filing →
-
10 August 2026 ·
Clarification Letter In Respect Of Outcome Of Board Meeting Held On 08.08.2026
Please find attached Clarification letter in respect of Outcome of Board meeting held on 08.08.2026 and submitted on 08.08.2026 for approval of Preferential issue of Shares
Company Update / General View filing →
-
5 August 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Saturday, August 8, 2026
Aptus Pharma Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/08/2026 ,inter alia, to consider and approve Intimation of Board Meeting to ....
Board Meeting / Board Meeting View filing →
RSS feed for Aptus Pharma Ltd · the 50 most recent filings